Showing results (2041-2050 of 2,138) with videos related to
Sort By:
Pageof 214
Mbio|March 3, 2021
A Mycobacterial Systems Resource for the Research CommunityJ A Judd, J Canestrari, R Clark, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.Blood Advances|December 5, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.Blood Advances|December 5, 2023
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, et al.Cancer Research|July 7, 2026
Targeting Cystine Addiction Suppresses Breast Cancer Lung MetastasisJosep Tarragó-Celada, Asad S Mahmood, Yulia Panina, et al.Molecular and Cellular Biology|August 26, 2009
Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppressionJennifer Rhodes, Adam Amsterdam, Takaomi Sanda, et al.Blood|February 18, 2021
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurinLaura K Schmalbrock, Anna Dolnik, Sibylle Cocciardi, et al.Haematologica|July 15, 2021
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Hatice G Ozer, Deedra Nicolet, et al.The British Journal of Nutrition|December 8, 2010
Proceedings of the Rank Forum on Vitamin DS A Lanham-New, J L Buttriss, L M Miles, et al.Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.Pageof 214